Tech Company Financing Transactions

Interius BioTherapeutics Funding Round

Interius BioTherapeutics, based in Philadelphia, secured $76 million in investment from Cormorant Asset Management, Fairmount Funds Management and Agent Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

3401 Grays Ferry Ave. Building 200 300
Philadelphia, PA 19146
USA

Phone

Undisclosed

Website

www.interiusbio.com

Email Address

Not Recorded

Overview

Interius BioTherapeutics is a biopharmaceutical company that targets cancer. The company spun out the University of Pennsylvania and is targeting cancer.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Philip Johnson

        

Founder

Saar Gill

        

Founder

Bruce Peacock

        

VP - Operations

Dora Mitchell

        

VP - R & D

Brian Busser

        

Browse more venture capital transactions:

Prev: 5/19/2021: Vise venture capital transaction
Next: 5/19/2021: Explorium venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary